2026 absorbs elevated cocoa costs and weak developed-market volumes, while management targets a significant chocolate-margin recovery in 2027 [29][75].
| Quarter | Q4 FY25 |
|---|---|
| Call date | 2026-02-17 |
| Length | 40 minutes |
| EPS | $0.72 |
| EPS consensus | $0.70 |
| Revenue | $10.5B |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY26
All MDLZ earnings ยท Back to MDLZ overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.